MSC-derived exosomes
KY20230214-V04
Phase 1 mab active
Quick answer
MSC-derived exosomes for Long COVID-19 Syndrome is a Phase 1 program (mab) at Regen BioPharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regen BioPharma Inc
- Indication
- Long COVID-19 Syndrome
- Phase
- Phase 1
- Modality
- mab
- Status
- active